Article
BRIX1 Promotes Hepatocellular Carcinoma Progression via the MAPK/ERK Pathway and Serves as a Prognostic Biomarker
2026-08-31
Abstract excerpt
Hepatocellular carcinoma (HCC) is particularly aggressive and difficult to treat. Due to the lack of early clinical diagnosis and the unsatisfactory clinical treatment effect, it is particularly important to identify novel markers that can predict tumor behavior in HCC. biogenesis of ribosomes BRX1 (BRIX1) is abundant in various tissues of the human body. However, the regulatory mechanisms and its role in various...
Identifiers and source
- Literature Corpus work
- ce7a48f6-d3fd-5a09-9e70-98bbbf9be6c0
- DOI
- 10.64898/2026.08.26.747409
